Trial · NCT00556400
Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones
NCT00556400, Phase 1, Phase 2, Terminated, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); results first posted 2013-07-11
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones. Trials, record NCT00556400. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00556400
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones
- NCT number
- NCT00556400
- Status
- Terminated
- Phases
- Phase 1, Phase 2
- Enrollment
- 1 participants, actual
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Conditions
- Aplastic Anemia, Menorrhagia, Amenorrhea
- Interventions
- Lo-Ovral Oral Contraceptive Pills, Placebo - sugar pill
- First posted
- 2007-11-12
- Last updated
- 2013-07-19
- Results first posted
- 2013-07-11
- Limitations and caveats
- Early termination because of insufficient accrual. With only one study participant, data could not be analyzed.
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Stop Vaginal Bleeding or Spotting. | 1 week | |
| Secondary | Proportion Who Stop Uterine Bleeding by Day 14. | 2 weeks | |
| Secondary | Total Number of Bleeding Days During the First 7 Days. | 1 week |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Stop Vaginal Bleeding or Spotting. | 1 week | Early termination because of insufficient accrual. With only one study participant, data could not be analyzed. | ||
| SECONDARY | Proportion Who Stop Uterine Bleeding by Day 14. | 2 weeks | Early termination because of insufficient accrual. With only one study participant, data could not be analyzed. | ||
| SECONDARY | Total Number of Bleeding Days During the First 7 Days. | 1 week | Early termination because of insufficient accrual. With only one study participant, data could not be analyzed. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Lo-ovral | 1 | |
| Overall Study | STARTED | Sugar Pill | 0 | |
| Overall Study | COMPLETED | Lo-ovral | 1 | |
| Overall Study | COMPLETED | Sugar Pill | 0 | |
| Overall Study | NOT COMPLETED | Lo-ovral | 0 | |
| Overall Study | NOT COMPLETED | Sugar Pill | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Sugar Pill | ||
| Total, other adverse events | Sugar Pill | 0 | 0 |
| Total, serious adverse events | Sugar Pill | 0 | 0 |
Source ClinicalTrials.gov
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00556400
GET https://conductscience.org/api/trials/v1/NCT00556400/registered